National Healthcare Properties, Inc. (NHP) Key Metrics
NHP valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $1.10B
- Enterprise value
- $1.79B
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 3.2
- Price / book
- 1.1
- EV / EBITDA
- 21.1
- Dividend yield
- 1.21% $0.30 a year
- Beta
- —
NHP key metrics, 2022–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNHP returns How much profit the business earns on the capital it uses.
NHP per-share figures Results divided by the shares outstanding at year-end.
NHP financial health Debt, liquidity and how easily interest is covered.
NHP efficiency & capital use Working capital cycle and where the cash goes.
NHP returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NHP debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NHP cash returned to shareholders
NHP key metrics
2022–2025| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Per share | ||||
| Revenue per share | $12.09 | $12.51 | $12.23 | $11.88 |
| Earnings per share | −$2.04 | −$6.71 | −$2.56 | −$2.81 |
| Operating cash flow per share | $0.25 | −$2.82 | $0.76 | $1.00 |
| Free cash flow per share | −$0.77 | −$3.60 | −$0.03 | $0.01 |
| Cash per share | $2.04 | $0.77 | $1.64 | $1.90 |
| Book value per share | $21.19 | $24.20 | $31.62 | $35.12 |
| Tangible book value per share | $12.49 | $24.20 | $31.62 | $35.12 |
| Dividends per share | $0.47 | $0.49 | $0.49 | $0.49 |
| Capex per share | $1.01 | $0.77 | $0.79 | $0.99 |
| Debt per share | $36.92 | $40.64 | $41.66 | $20.48 |
| Shares outstanding | 28.3M | 28.3M | 28.3M | 28.3M |
| Change in shares outstanding | +0.1% | +0.0% | +0.1% | — |
| Returns & profitability | ||||
| Return on equity (ROE) | −9.0% | −24.0% | −7.7% | −8.0% |
| Return on invested capital (ROIC) | 0.2% | −5.1% | −0.2% | −1.6% |
| Return on assets (ROA) | −3.2% | −9.3% | −3.3% | −3.6% |
| Return on tangible assets | −3.9% | −9.7% | −3.4% | −3.6% |
| Free cash flow margin | −6.4% | −28.8% | −0.2% | 0.1% |
| Financial health | ||||
| Total debt | $1.05B | $1.15B | $1.18B | $578.7M |
| Cash & short-term investments | $57.6M | $21.7M | $46.4M | $53.7M |
| Net debt | $987.6M | $1.13B | $1.13B | $525.0M |
| Debt / equity | 1.74 | 1.68 | 1.32 | 0.58 |
| Debt / assets | 0.61 | 0.59 | 0.55 | 0.27 |
| Net debt / EBITDA | 12.04 | — | 14.72 | 9.65 |
| Current ratio | 0.24 | 0.22 | 0.28 | 0.17 |
| Quick ratio | 0.24 | 0.22 | 0.28 | 0.17 |
| Interest coverage | 0.1 | -1.8 | -0.1 | -0.6 |
| Working capital | −$438.5M | −$359.7M | −$301.7M | −$483.2M |
| Invested capital | $1.59B | $1.81B | $2.03B | $1.52B |
| Tangible asset value | $358.0M | $690.1M | $900.6M | $999.2M |
| Net current asset value | −$968.1M | −$1.15B | −$1.13B | −$1.08B |
| Graham net-net per share | −$36.26 | −$42.87 | −$41.67 | −$39.23 |
| Capital allocation | ||||
| Dividends paid | $13.4M | $13.8M | $13.8M | $13.8M |
| Share buybacks (net) | $5.4M | $0 | $0 | $42,000 |
| Capex / revenue | 8.4% | 6.2% | 6.5% | 8.3% |
| Capex / operating cash flow | 413.3% | — | 103.6% | 98.9% |
| Capex / depreciation | 0.37 | 0.26 | 0.27 | 0.34 |
| Stock-based compensation / revenue | 1.1% | 0.2% | 0.3% | 0.4% |
| SG&A / revenue | 7.1% | 6.3% | 5.5% | 5.1% |
| Efficiency | ||||
| Days sales outstanding | 31.7 | 28.4 | 27.2 | 27.5 |
| Days payables outstanding | 111.7 | 113.7 | 78.4 | 77.4 |
| Cash conversion cycle (days) | -80.0 | -85.3 | -51.2 | -49.9 |
| Receivables turnover | 11.52 | 12.86 | 13.41 | 13.29 |
| Payables turnover | 3.27 | 3.21 | 4.65 | 4.72 |
| Asset turnover | 0.19 | 0.17 | 0.16 | 0.15 |
| Average receivables | $29.7M | $27.5M | $25.8M | $25.3M |
| Average payables | $67.0M | $69.0M | $46.8M | $45.2M |
| Intangibles / total assets | 14.4% | 0.0% | 0.0% | 0.0% |
Computed from NHP's annual financial statements (latest annual report filed February 20, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NHP valuation and financial ratios
National Healthcare Properties earned a return on equity of −9.0% and a return on invested capital of 0.2% in fiscal 2025. It ended the year with $1.0 billion of debt and $57.6 million in cash and short-term investments, net debt of $987.6 million. It returned $18.9 million to shareholders: $13.4 million in dividends and $5.4 million in share buybacks.
See the NHP income statement, the NHP chart for price history, or the NHP stock overview for the latest quote and news.
NHP key metrics FAQ
What is National Healthcare Properties's return on equity?
National Healthcare Properties's return on equity (ROE) was −9.0% in fiscal 2025: net income of -$57.6 million on average shareholders' equity of $642.3 million.
What is National Healthcare Properties's ROIC?
National Healthcare Properties's return on invested capital was 0.2% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does National Healthcare Properties have?
National Healthcare Properties had total debt of $1.0 billion at the end of fiscal 2025, a debt-to-equity ratio of 1.74 and $987.6 million of net debt (12.04 times EBITDA).
Does National Healthcare Properties buy back its shares?
Yes. National Healthcare Properties spent $5.4 million on net share repurchases in fiscal 2025 Shares outstanding changed +0.1% over the year, to 28.3M..
What is National Healthcare Properties's current ratio?
National Healthcare Properties's current ratio was 0.24 at the end of fiscal 2025: current assets were 0.24 times current liabilities.